Chapter 12: Central Nervous System Depressants and Muscle Relaxants

Central nervous system depressants including barbiturates, benzodiazepines, and nonbenzodiazepine hypnotics work by enhancing gamma-aminobutyric acid activity within the brain, thereby decreasing neuronal firing and producing sedative, hypnotic, and anticonvulsant effects. These medications are used therapeutically for insomnia management, anxiety reduction, seizure prevention, and preoperative sedation, though their mechanisms differ slightly among drug classes. Muscle relaxants such as baclofen, cyclobenzaprine, dantrolene, and tizanidine operate through distinct pathways at the spinal cord or skeletal muscle level to diminish spasticity and musculoskeletal pain associated with conditions like multiple sclerosis, cerebral palsy, and spinal cord injuries. The chapter emphasizes critical safety considerations including the development of physical and psychological dependence, tolerance with prolonged use, respiratory depression risks, and potentially life-threatening interactions when these agents are combined with alcohol or opioid medications. Nursing responsibilities encompass comprehensive patient assessment before drug initiation, continuous monitoring for adverse effects including hypotension, dizziness, and altered mental status, and implementation of evidence-based patient education regarding appropriate medication use and potential hazards. The chapter distinguishes between therapeutic categories by explaining how sedatives produce mild central nervous system depression, hypnotics induce sleep, anxiolytics reduce anxiety symptoms, and muscle relaxants specifically target skeletal muscle tension. Understanding these pharmacological distinctions enables nurses to provide safe, effective medication management while recognizing contraindications, identifying signs of drug abuse or dependence, and implementing interventions that minimize oversedation while optimizing therapeutic outcomes for diverse patient populations.